Page 192 - Traité de Chimie Thérapeutique 4 Médicaments en relation avec des systèmes hormonaux

2. médicaments du diabète sucré utilisables par voie orale 153

CREUTZFELDT W., (edit.) Acarbose for the treatment of diabètes mellitus Proceedings
of the 2d International symposium on Acarbose. Berlin, Springer Verlag, Berlin
1988.
JOUBERT P.H., VENTER H.L. et FOUKARIDIS G.N. The effect of miglitol and acar­
bose after an oral glucose load : a novel hypoglycaemic mechanism. Br. J. clin.
Pharmac., 1990, 30, 391-396.
DOLLERY C., (edit) Acarbose in dictionnary of drugs, Churchill-Livingston, Edinburgh
1991, A1-A4.
PAPANDREOU G., TONG M.K. et GANEM B., Amidine, amidrazone and amidoxime
dérivatives of monosaccharide aldonolactams : synthesis and évaluation as glyco­
sidase inhibitors. J. Am. Chem. Soc., 1993,115, 11682-11690.
Acarbose-an a-glucosiduse inhibitor. International Pharmacy Journal, 1994, 8, 11-13.
Miglitol et émiglitate
Miglitol &emiglitate. Drugs of the future, 1986,11,1039-1043.
JOUBERT P.H., VENTER H.L. et FOUKARIDIS G.N., The effect of miglitol and acar­
bose after an oral glucose load : A novel hypoglycaemic mechanism ? Br. J. Clin.
Pharmac., 1990, 30, 391-396.
Emiglitate. Drugs ofthe future, 1992,17,1130.
Miglitol. Drugs ofthe future, 1992, 17, 1134-1135.
Utilisations
HOLLANDER P., Safety profile of acarbose, an a-glucosidase inhibitor. Drugs, 1992,
44 (suppl 2), 47-53.
ZIMMERMAN B.R., Preventing long term complications. Implications for combination
therapy with acarbose. Drugs, 1992, 44 (suppl 2) 54-59.
TOELLER M., Nutritional recommendations for diabetic patients and treatment with a-
glucosidase inhibitors. Drugs, 1992, 44 (suppl 2), 13-20.
Alcaloïdes dérivés de l'indolizine
KIM N.-S., CHOI J.-R., CHA J.K., A concise, enantioslective synthesis of castanosper-
mine, J. Org. Chem., 1993, 58, 7096-7099.